GRACE ZIMMERMAN: Open Payments
NPI 1205554987 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $409 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $249 |
| Otsuka America Pharmaceutical, Inc. | 2 | $158 |
| ABBVIE INC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| Janssen Pharmaceuticals, Inc | 1 | $91 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: COBENFY, REXULTI, VRAYLAR, CAPLYTA, INGREZZA, SPRAVATO, Auvelity, Qelbree.
Industry payments across AK — which companies pay providers there.
